Inside Long Island Business

Get the latest news and trends on Long Island companies and the people behind them.

Hi-Tech Pharmacal to abide by FDA warning on three cream medicines for diabetics

Hi-Tech Pharmacal of Amityville said July 24,

Hi-Tech Pharmacal of Amityville said July 24, 2013, that it had received a federal warning about three of its medicinal creams for diabetics. (Credit: Steve Pfost, 2012)

Hi-Tech Pharmacal Co. Wednesday said it would comply with a federal warning about labels on three of its medicinal creams for diabetics.

The Amityville-based manufacturer of generic and brand-name drugs said it had received a “warning letter” from the federal Food and Drug Administration on July 15. The letter “related to certain statements that appear in labeling” on the creams, the company said.

The creams are Diabeti-Derm Antifungal Cream and Zostrix Diabetic Foot Pain Relief Cream and Diabetic Joint & Arthritis Pain Relief Cream.

The three products generated $1.1 million in sales for the fiscal year ended April 30. Hi-Tech’s total sales for the year were $232 million.

Wednesday’s announcement came before the stock markets’ opening. In early trading, Hi-Tech shares were down 25 cents, or less than 1 percent, to $36.33.


MORE: This story is developing, click here for further details.


advertisement | advertise on newsday

advertisement | advertise on newsday